AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Krupitsky, EM Masalov, DV Didenko, TY Burakov, AM Romanova, TN Zvartau, EE Woody, G
Citation: Em. Krupitsky et al., Prevention of suicide by naltrexone in a recently detoxified heroin addict, EUR ADDIC R, 7(2), 2001, pp. 87-88

Authors: Forman, RF Bovasso, G Woody, G
Citation: Rf. Forman et al., Staff beliefs about addiction treatment, J SUBST ABU, 21(1), 2001, pp. 1-9

Authors: Belshe, RB Stevens, C Gorse, GJ Buchbinder, S Weinhold, K Sheppard, H Stablein, D Self, S McNamara, J Frey, S Flores, J Excler, JL Klein, M El Habib, R Duliege, AM Harro, C Corey, L Keefer, M Mulligan, M Wright, P Celum, C Judson, F Mayer, K McKirnan, D Marmor, M Woody, G
Citation: Rb. Belshe et al., Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers, J INFEC DIS, 183(9), 2001, pp. 1343-1352

Authors: Luborsky, L Stuart, J Friedman, S Diguer, L Seligman, DA Bucci, W Pulver, S Krause, ED Ermold, J Davison, WT Woody, G Mergenthaler, E
Citation: L. Luborsky et al., The Penn Psychoanalytic Treatment Collection: A set of complete and recorded psychoanalyses as a research resource, J AM PSYCHO, 49(1), 2001, pp. 217-234

Authors: Seage, GR Holte, SE Metzger, D Koblin, BA Gross, M Celum, C Marmor, M Woody, G Mayer, KH Stevens, C Judson, FN McKirnan, D Sheon, A Self, S Buchbinder, SP
Citation: Gr. Seage et al., Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study, AM J EPIDEM, 153(7), 2001, pp. 619-627

Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137

Authors: Sigueland, L Horn, A Moras, K Woody, G Weiss, R Blaine, J Bishop, S Barber, J Thase, M
Citation: L. Sigueland et al., Cocaine-induced mood disorder: Prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sample, AM J ADDICT, 8(2), 1999, pp. 165-169
Risultati: 1-7 |